Compare CVS Health Corp (CVS) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Workday Inc — how do they compare? CVS Health Corp trades at $86.85 (market cap $112.49B), while Workday Inc trades at $188.03 (market cap $44.41B). The key difference: CVS Health Corp is far larger — about 2.5× Workday Inc's market cap, and CVS Health Corp pays a 3.02% dividend while Workday Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Workday Inc for 38 Days on average.
| CVS | WDAY | |
|---|---|---|
Market Cap | $112.49B | $44.41B |
Volume | 8,467,392 | 1,519,068 |
Sector | Health | Technology |
52-Week High | $110.60 | $245.67 |
52-Week Low | $70.08 | $112.55 |
Typical Hold Time | 83 Days | 38 Days |
Enterprise Value | $174.83B | $44.78B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Workday (WDAY) trades at $187.81, up 0.68% with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth from $8.45B in 2025 to $10.2B projected for 2026, with net income margin improving to 12.31%. Recent developments include UAE market expansion and AI product launches, though layoffs and a fraud investigation present headwinds. Analyst consensus remains positive with a $202.92 price target.
WDAY's valuation appears stretched with a P/E of 37.53, but robust AI-driven growth and strategic partnerships support long-term upside. Key risks include integration execution, competitive pressures, and ongoing legal scrutiny. The stock offers growth exposure with moderate risk for investors comfortable with premium valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
